MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Alex Kirkham, Charles Jameson et al.|European Radiology|2017Cited by 36
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M. Moore, Mark Emberton, Nicola L. Robertson et al.|The Journal of Urology|2016Cited by 28